1. ROBERT HARRIS, PH.D.
11668 Kiowa Ave #105
Los Angeles CA 90049
763-232-1487
harris06@ucla.edu
PUBLICATIONS
1. Harris RJ, Cloughesy TF, Liau LM, Nghiemphu PL, Lai A, Pope WB, Ellingson BM. Simulation,
phantom validation and clinical evaluation of fast pH-weighted molecular imaging using amine chemical
exchange saturation transfer echo planar imaging (CEST-EPI) in glioma at 3T. NMR in Biomed 2016;
[Epub ahead of print]
2. Harris RJ, Cloughesy TF, Liau LM, Prins RM, Antonios JP, Li D, Yong WH, Pope WB, Lai A,
Nghiemphu PL, Ellingson BM. pH-weighted molecular imaging of gliomas using amine chemical
exchange saturation transfer MRI. Neuro Oncol 2015; 17(11):1514-24
3. Harris RJ, Cloughesy TF, Hardy AJ, Liau LM, Pope WB, Nghiemphu PL, Lai A, Ellingson BM. MRI
perfusion measurements calculated using advanced deconvolution techniques predict survival in recurrent
glioblastoma treated with bevacizumab. J Neurooncol 2015; 122(3):497-505.
4. Harris RJ, Bookheimer SY, Cloughesy TF, Kim HJ, Pope WB, Lai A, Nghiemphu PL, Liau LM,
Ellingson BM. Altered functional connectivity of the default mode network in diffuse gliomas measured
with pseudo-resting state fMRI. J Neurooncol 2013; 116(2):373-9.
5. Harris RJ, Cloughesy TF, Pope WB, Godinez S, Natsuaki Y, Nghiemphu PL, Meyer H, Paul D,
Behbahanian Y, Lai A, Ellingson BM. Pre- and post-contrast three-dimensional double inversion-recovery
MRI in human glioblastoma. J Neurooncol 2013; 112(2):257-66.
6. Harris RJ, Cloughesy TF, Pope WB, Nghiemphu PL, Lai A, Zaw T, Czernin J, Phelps ME, Chen W,
Ellingson BM. 18
F-FDOPA and 18
F-FLT positron emission tomography parametric response maps (PET
PRMs) predict response in recurrent malignant gliomas treated with bevacizumab. Neuro Oncol 2012;
14(8): 1079-89.
7. Ellingson BM, Harris RJ, Woodworth DC, Leu K, Zaw O, Mason WP, Sahebjam S, Abrey LE, Aftab DT,
Schwab GM, Hessel C, Lai A, Nghiemphu PL, Pope WB, Wen PY, Cloughesy TF. Baseline pretreatment
contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent
glioblastoma: evidence from single- and multicenter trials. Neuro Oncol 2016; [Epub ahead of print]
8. Banerjee P, Leu K, Harris RJ, Cloughesy TF, Lai A, Nghiemphu PL, Pope WB, Bookheimer SY,
Ellingson BM. Association between lesion location and language function in adult glioma using voxel-
based lesion-sympton mapping. Neuroimage Clin 2015; 9:617-24.
9. Yogi A, Hirata Y, Karavaeva E, Harris RJ, Wu JY, Yudovin SL, Linetsky M, Mathern GW, Ellingson
BM, Salamon N. DTI of tuber and perituberal tissue can predict epileptogenicity in tuberous sclerosis
complex. Neurology 2015; 85(23):2011-5
10. Karavaeva E, Harris RJ, Leu K, Shabihkhani M, Yong WH, Pope WB, Lai A, Nghiemphu PL, Liau LM,
Chen W, Czernin J, Cloughesy TF, Ellingson BM. Relationship between [18F]FDOPA PET uptake,
Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas. Mol
Imaging Biol 2015; 434-42.

2. 11. Chang W, Pope WB, Harris RJ, Hardy AJ, Leu K, Mody RR, Nghiemphu PL, Lai A, Cloughesy TF,
Ellingson BM. Diffusion MR Characteristics Following Concurrent Radiochemotherapy Predicts
Progression-Free and Overall Survival in Newly Diagnosed Glioblastoma. Tomography 2015; 1(1):37-43.
12. Ellingson BM, Kim HJ, Woodworth DC, Pope WB, Cloughesy TF, Harris RJ, Lai A, Nghiemphu PL,
Cloughesy TF. Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted
subtraction maps improve tumor delineation and predict survival in a multicenter clinical trial. Radiology
2014; 271(1):200.
13. Ellingson BM, Sahebjam S, Kim HJ, Pope WB, Harris RJ, Woodworth DC, Lai A, Nghiemphu PL,
Mason WP, Cloughesy TF. Pretreatment ADC histogram analysis is a predictive imaging biomarker for
bevacizumab treatment but not chemotherapy in recurrent glioblastoma. Am J Neuroradiol 2014;
35(4):673-9.
14. Tran AN, Lai A, Li S, Pope WB, Teixeira S, Harris RJ, Woodworth DC, Nghiemphu PL, Cloughesy TF,
Ellingson BM. Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated
by serial quantitative MR volumetry. Neuro Oncol 2014; 16(3):414-20.
15. Leu K, Enzmann DR, Woodworth DC, Harris RJ, Tran AN, Lai A, Nghiemphu PL, Pope WB, Cloughesy
TF, Ellingson BM. Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood
volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab. Cancer
Imaging 2014; 14:31.
16. Boxerman JL, Ellingson BM, Jeyapalan S, Elinzano H, Harris RJ, Rogg JM, Pope WB, Safran H.
Longitudinal DSC-MRI for Distinguishing Tumor Recurrence from Pseudoprogression in Patients With a
High-grade Glioma. Am J Clin Oncol 2014. [Epub]
17. Naeini KM, Pope WB, Cloughesy TF, Harris RJ, Lai A, Askin A, Chowdhury R, Phillips HS, Nghiemphu
PL, Behbahanian Y, Ellingson BM. Identifying the mesenchymal molecular subtype of glioblastoma using
quantitative volumetric analysis of anatomic magnetic resonance images. Neuro Oncol 2013; 15(5):626-34.
18. Ellingson BM, Lai A, Harris RJ, Selfridge JM, Yong WH, Das K, Pope WB, Nghiemphu PL, Vinters HV,
Liau LM, Mischel PS, Cloughesy TF. Probabilistic Radiographic Atlas of Glioblastoma Phenotypes. Am J
Neuroradiol 2013; 34(3):533-40.
19. Ellingson BM, Chen W, Harris RJ, Pope WB, Lai A, Nghiemphu PL, Czernin J, Phelps ME, Cloughesy
TF. PET Parametric Response Mapping for Clinical Monitoring and Treatment Response Evaluation in
Brain Tumors. PET Clinics 2013; 8(2): 201-217.
20. Ellingson BM, Mayer E, Harris RJ, Ashe-McNally C, Naliboff BD, Labus JS, Tillisch K. Diffusion tensor
imaging detects microstructural reorganization in the brain associated with chronic irritable bowel
syndrome. Pain 2013; 154(9):1528-41.
21. Ellingson BM, Cloughesy TF, Zaw TM, Lai A, Nghiemphu PL, Harris RJ, Lalezari S, Wagle N, Naeini
KM, Carrillo J, Liau LM, Pope WB. Functional diffusion maps (fDMs) evaluated before and after
radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma. Neuro
Oncol 2012; 14(3):333-43.
22. Ellingson BM, Cloughesy TF, Pope WB, Zaw TM, Phillips H, Lalezari S, Nghiemphu PL, Ibrahim H,
Naeini KM, Harris RJ, Lai A. Anatomic Localization of O6-methylguanine DNA methyltransferase
(MGMT) promoter methylated and unmethylated tumors: a radiographic study in 358 de novo human
glioblastomas. Neuroimage 2012; 59(2):908-16.

3. CONFERENCE PRESENTATIONS
Oral
1. Harris RJ, Leu K, Pope WB, Cloughesy TF, Ellingson BM. Fast Whole Brain Multispectral pH-weighted
Molecular MRI in Human Gliomas Using Multi-Echo Amine CEST-EPI. American Society of
Neuroradiology (ASNR), Chicago, IL, May 23-26, 2016.
2. Ellingson BM, Pope WB, Cloughesy TF. Growth Dynamics and Measurement Bias in Pre-Operative,
Treatment Naïve Human Glioblastoma. American Society of Neuroradiology (ASNR), Chicago, IL, May
23-26, 2016. [Presented for Dr. Ellingson].
3. Harris RJ, Pghiemphu P, Lai A, Pope WB , Cloughesy TF, Prins R, Yong W, Liau LM, Ellingson BM.
PH-weighed molecular MRI in preclinical and human brain tumors. American Society of Neuroradiology
(ASNR), Chicago, IL, Apr 26-29, 2015.
4. Harris RJ, Bookheimer S, Cloughesy TF, Pope WB, Ellingson BM. Alterations in functional connectivity
of the default mode network in malignant glioma patients as measured by pseudo-resting state fMRI.
American Society of Neuroradiology (ASNR), San Diego, CA, May 18-23, 2013.
5. Woodworth DC, Cloughesy TF, Kim HJ, Harris RJ, Lai A, Nghiemphu PL, Pope WB, Ellingson BM.
Intensity-normalized T1 subtraction maps improve quantification of contrast enhancing tumor burden and
predict survival in recurrent glioblastoma treated with bevacizumab: Evaluation in a single institution and a
multi-center clinical trial. American Society of Neuroradiology (ASNR), San Diego, CA, May 18-23,
2013. [Presented for Woodworth].
6. Ellingson BM, Mayer E, Harris RJ, Ashe-McNally C, Naliboff B, Labus JS, Tillisch K. Diffusion tensor
imaging (DTI) detects microstructural reorganization in the brain associated with chronic irritable bowel
syndrome (IBS). American Society of Neuroradiology (ASNR), San Diego, CA, May 18-23, 2013.
[Presented for Dr. Ellingson].
Poster
7. Harris RJ, Cloughesy TF, Linda LM, Li D, Pope WB, Ellingson BM. CEST MRI of the Amino Acid
Amine Group Provides a pH-weighted Biomarker in Human Gliomas. National Institute of Biomedical
Engineering and Bioengineering (NIBIB) Training Grantees Meeting, Bethesda, MD, June 5-6, 2014.
8. Harris RJ, Cloughesy TF, Pope WB, Nghiemphu PL, Lai A, Zaw T, Chen W, Ellingson BM. 18
F-FDOPA
and 18
F-FLT positron emission tomography parametric response maps (PET PRMs) predict survival in
recurrent malignant gliomas treated with bevacizumab. Society for Neuro-oncology (SNO), Orange
County, CA, Nov 17-20, 2011.